2025 年神經技術全球市場報告

預計未來幾年神經技術市場規模將快速成長。到 2029 年，這一數字將成長至 298 億美元，複合年成長率為 14.4%。預測期內的成長歸因於監管發展、基因組學和神經系統疾病、神經病學遠端醫療、精準醫療的採用以及閉合迴路系統的發展。預測期內的關鍵趨勢包括神經資訊學、神經可塑性干預、腦映射舉措、遠端監控解決方案和非侵入性腦刺激的進步。

預計神經系統疾病盛行率的增加將在未來幾年推動神經技術市場的成長。神經系統疾病包括多種影響大腦的疾病和病症，例如阿茲海默症、帕金森氏症、癲癇和偏頭痛。神經技術透過腦部影像、神經刺激、神經回饋和腦機介面等方法在診斷和治療這些疾病方面發揮重要作用。例如，截至 2022 年 1 月，美國心臟協會預測，到 2060 年，阿茲海默症和相關失智症將影響美國約 930 萬人。此外，根據世界衛生組織 (WHO) 2023 年 2 月的數據，預計全球每年將有 500 萬人被診斷出患有癲癇。因此，神經系統疾病發生率的不斷上升正在推動神經技術市場的成長。

預計未來幾年醫療保健支出的增加將推動神經技術市場的成長。醫療保健支出是指特定醫療保健系統或經濟體在醫療保健相關商品和服務上的總支出。這些支出將透過刺激研究、改善先進設備的使用、加強教育和培訓、促進臨床試驗、確保法律規範以及使需要神經系統護理的患者更容易獲得創新療法來支持神經技術的開發和實施。例如，2022年，英國國家統計機構國家統計局報告稱，英國醫療保健支出達到約3,548.8億美元（2,830億英鎊），比上一年名義增加0.7%。因此，醫療保健支出的增加正在推動神經技術市場的成長。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第 4 章市場：宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情以及復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球神經科技 PESTEL 分析（政治、社會、科技、環境、法律因素、促進因素、限制因素）
• 最終用途產業分析
• 全球神經技術市場：成長率分析
• 全球神經技術市場表現：規模與成長，2019 年至 2024 年
• 全球神經技術市場預測：2024-2029 年及 2034 年規模與成長
• 全球神經技術總目標市場 (TAM)

第6章 市場細分

• 全球神經技術市場狀況、表現及預測，2019-2024 年、2024-2029 年、2034 年
• 認知障礙
• 治療疼痛
• 尿失禁和大便失禁
• 癲癇
• 帕金森氏症
• 聽力障礙
• 睡眠障礙
• 憂鬱症
• 其他條款
• 全球神經技術市場：按類型、表現和預測，2019-2024 年、2024-2029 年、2034 年
• 診斷影像設備
• 神經刺激
• 頭骨表面測量
• 神經植入
• 其他類型
• 全球神經技術市場依最終用途、性能和預測，2019-2024 年、2024-2029 年、2034 年
• 門診手術中心
• 醫院
• 居家照護設施
• 其他用途
• 全球神經技術市場、認知障礙細分、類型、表現和預測，2019-2024 年、2024-2029 年、2034 年
• 阿茲海默症
• 注意力不足過動症(ADHD)
• 失智
• 全球神經科技市場、疼痛治療細分、類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 慢性疼痛
• 神經病變疼痛
• 急性疼痛
• 全球神經技術市場 - 尿失禁和大便失禁細分類型、表現和預測，2019-2024 年、2024-2029 年、2034 年
• 膀胱過動症
• 神經源性膀胱
• 大便失禁管理
• 全球神經技術市場，癲癇分類、類型、表現和預測，2019-2024 年、2024-2029 年、2034 年
• 抗藥性癲癇
• 癲癇管理設備
• 帕金森氏症細分領域的全球神經技術市場，按類型、表現和預測，2019-2024 年、2024-2029 年、2034 年
• 運動症狀的管理
• 非運動症狀的治療
• 全球神經技術市場細分（按聽力障礙類型分類）、實際值和預測值，2019-2024 年、2024-2029 年、2034 年
• 耳鳴
• 聽力損失的解決方案
• 全球神經技術市場睡眠障礙細分市場，按類型、表現和預測，2019-2024 年、2024-2029 年、2034 年
• 失眠
• 睡眠呼吸中止症
• 不寧腿
• 全球神經技術市場、憂鬱症細分、類型、表現和預測，2019-2024 年、2024-2029 年、2034 年
• 重度憂鬱症
• 抗治療性憂鬱症
• 全球神經技術市場、其他適應症細分、按類型、績效和預測，2019-2024 年、2024-2029 年、2034 年
• 焦慮症
• 泛自閉症障礙
• 創傷性腦損傷 (TBI)

第7章 區域和國家分析

• 全球神經技術市場：按地區、表現和預測，2019-2024 年、2024-2029 年、2034 年
• 全球神經技術市場：按國家、表現和預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第 17 章 德國市場

第 18 章 法國市場

第 19 章：義大利市場

第 20 章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第 25 章：加拿大市場

第26章 南美洲市場

第 27 章：巴西市場

第28章 中東市場

第 29 章：非洲市場

第 30 章競爭格局與公司概況

• 神經技術市場：競爭格局
• 神經技術市場：公司簡介
  • General Electric Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
  • Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis
  • Shimadzu Corporation Overview, Products and Services, Strategy and Financial Analysis
  • EndoStim Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

• Elekta AB
• Natus Medical Incorporated
• Abbott
• Boston Scientific Corporation
• Cleveland Medical Devices Inc.
• Nihon Kohden Corporation
• LivaNova PLC
• Siemens Healthcare Private Limited
• Hitachi Medical Corporation
• Cochlear Limited
• Advanced Bionics AG（Sonova）
• NeuroPace Inc.
• NeuroSigma Inc.
• NeuroMetrix Inc.
• NeuroSky Inc.

第 32 章 全球市場競爭基準化分析與儀表板

第33章 重大併購

第 34 章 近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

• 2029 神經科技市場：提供新機會的國家
• 2029 神經科技市場：提供新機會的細分市場
• 2029 神經科技市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第 36 章 附錄

Neurotechnology involves the study and interaction with the nervous system, encompassing the brain and other components of the nervous system. In clinical settings, neurotechnology is utilized to influence the brain or nervous system, often in therapeutic or rehabilitative contexts.

The primary neurotechnology applications include addressing conditions such as cognitive disorders, pain treatment, urinary and fecal incontinence, epilepsy, Parkinson's disease, hearing conditions, sleep disorders, depression, and various others. Cognitive disorders signify a significant decline in an individual's cognitive function to an extent that, without treatment, regular social activities become challenging. The diverse types of neurotechnology include imaging modalities, neurostimulation, cranial surface measurement, neurological implants, and others. These technologies find application in ambulatory surgical centers, hospitals, homecare facilities, and other medical settings.

The neurotechnology market research report is one of a series of new reports from The Business Research Company that provides neurotechnology market statistics, including neurotechnology industry global market size, regional shares, competitors with a neurotechnology market share, detailed neurotechnology market segments, market trends and opportunities, and any further data you may need to thrive in the neurotechnology industry. This neurotechnology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The neurotechnology market size has grown rapidly in recent years. It will grow from $15.38 billion in 2024 to $17.39 billion in 2025 at a compound annual growth rate (CAGR) of 13.1%. The growth in the historic period can be attributed to increased research funding, aging population, neurological disorders prevalence, regulatory support, government initiatives.

The neurotechnology market size is expected to see rapid growth in the next few years. It will grow to $29.8 billion in 2029 at a compound annual growth rate (CAGR) of 14.4%. The growth in the forecast period can be attributed to regulatory advancements, genomics and neurological disorders, telemedicine in neurology, precision medicine adoption, development of closed-loop systems. Major trends in the forecast period include neuroinformatics advancements, neuroplasticity interventions, brain mapping initiatives, remote monitoring solutions, non-invasive brain stimulation.

The anticipated increase in the prevalence of neurological conditions is set to drive the growth of the neurotechnology market in the coming years. Neurological conditions encompass various disorders or diseases affecting the brain, including Alzheimer's disease, Parkinson's disease, epilepsy, and migraine. Neurotechnology is playing a crucial role in diagnosing and treating these conditions through methods such as brain imaging, neurostimulation, neurofeedback, and brain-computer interfaces. For example, as of January 2022, the American Heart Association Inc. projected that Alzheimer's disease and related dementias would impact approximately 9.3 million people in the United States by 2060. Additionally, according to the World Health Organization (WHO) in February 2023, an estimated 5 million people worldwide are expected to be diagnosed with epilepsy annually. Therefore, the increasing prevalence of neurological conditions is a driving force behind the growth of the neurotechnology market.

The increasing healthcare expenditure is expected to propel the growth of the neurotechnology market in the coming years. Healthcare expenditure refers to the total spending on healthcare-related goods and services within a particular healthcare system or economy. This spending supports the development and implementation of neurotechnology by promoting research, improving access to advanced equipment, enhancing education and training, facilitating clinical trials, ensuring regulatory oversight, and making innovative treatments more accessible for patients requiring neurological care. For instance, in 2022, the Office for National Statistics, a UK-based national statistics organization, reported that UK healthcare expenditure reached approximately $354.88 billion (£283 billion), representing a nominal increase of 0.7% compared to the previous year. Thus, the rise in healthcare expenditure is driving the growth of the neurotechnology market.

Technological advancements represent a significant trend gaining momentum in the neurotechnology market, with companies adopting innovative technologies to maintain their market positions. For instance, in November 2022, Blackrock Neurotech, a biotechnology company based in the United States, introduced Neuralace, a next-generation technology in neurotechnology. Neuralace, resembling a lace thinner than an eyelash, can cover large areas of the brain's surface. Designed as an ultra-high channel count, flexible electrode, Neuralace provides insights into the technology powering future brain-computer interfaces (BCIs). The system assists patients in regaining tactile function, limb and prosthetic movement, and the ability to control digital devices.

Major players in the neurotechnology market are concentrating on developing advanced therapeutic solutions, including the endovascular brain-computer interface (BCI), to enhance cognitive function and restore mobility for patients with neurological impairments. The endovascular BCI allows for direct neural access through blood vessels, enabling better interaction and treatment options for individuals with neurological disorders. For instance, in April 2024, Synchron, a Sweden-based software company specializing in advanced synchronization technologies for seamless data integration and management, launched the Patient Registry for its Stentrode Brain-Computer Interface. This technology is designed to interpret brain signals and restore motor intent, allowing individuals with limited mobility to control digital devices hands-free. Implanted via a non-invasive endovascular procedure, it wirelessly transmits motor intent from the brain, helping severely paralyzed patients regain independence. This groundbreaking technology marks a significant advancement in assistive solutions, facilitating daily activities such as communication and access to essential services.

In April 2022, Blackrock Neurotech, a U.S.-based biotechnology company, acquired Mindx Corporation for an undisclosed amount. This acquisition expands Blackrock's software portfolio and positions the company to offer integrated BCI products with cutting-edge features, enhancing its ability to provide a full-stack solution to customers. Mindx Corporation, based in the United States, is known for developing a neuron technology framework for use in spatial computing applications.

Major companies operating in the neurotechnology market include General Electric, Medtronic PLC, Koninklijke Philips N.V., Shimadzu Corporation, EndoStim Inc., Elekta AB, Natus Medical Incorporated, Abbott, Boston Scientific Corporation, Cleveland Medical Devices Inc., Nihon Kohden Corporation, LivaNova PLC, Siemens Healthcare Private Limited, Hitachi Medical Corporation, Cochlear Limited, Advanced Bionics AG (Sonova), NeuroPace Inc., NeuroSigma Inc., NeuroMetrix Inc., NeuroSky Inc., NeuroVigil Inc., Neurotech Pharmaceuticals Inc., Neurotech International Limited, NeurotechEU, Neurotech Solutions, Neurotech Reports, Neurotech Research Development

North America was the largest region in the neurotechnology market in 2024. Europe is expected to be the fastest-growing region in the neurotechnology market report during the forecast period. The regions covered in the neurotechnology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the neurotechnology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The neurotechnology market includes revenues earned by entities from neuro-rehabilitative treatment, heart rate variability, electroencephalography, and neurostimulation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The neurotechnology market consists of sales of brain-computer interfaces (BCIs), neurostimulation devices, virtual reality (VR), and prosthetic limb devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neurotechnology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neurotechnology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neurotechnology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The neurotechnology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Conditions: Cognitive Disorders; Pain Treatment; Urinary And Faecal Incontinence; Epilepsy; Parkinson's Disease; Hearing Conditions; Sleep Disorder; Depression; Other Conditions
• 2) By Type: Imaging Modalities; Neurostimulation; Cranial Surface Measurement; Neurological Implants; Other Types
• 3) By End Use: Ambulatory Surgical Centers; Hospitals; Homecare Facilities; Other End Uses
• Subsegments:
• 1) By Cognitive Disorders: Alzheimer's Disease; Attention Deficit Hyperactivity Disorder (ADHD); Dementia
• 2) By Pain Treatment: Chronic Pain; Neuropathic Pain; Acute Pain
• 3) By Urinary And Fecal Incontinence: Overactive Bladder; Neurogenic Bladder; Fecal Incontinence Management
• 4) By Epilepsy: Drug-Resistant Epilepsy; Seizure Management Devices
• 5) By Parkinson's Disease: Motor Symptoms Management; Non-Motor Symptoms Management
• 6) By Hearing Conditions: Tinnitus; Hearing Loss Solutions
• 7) By Sleep Disorder: Insomnia; Sleep Apnea; Restless Legs Syndrome
• 8) By Depression: Major Depressive Disorder; Treatment-Resistant Depression
• 9) By Other Conditions: Anxiety Disorders; Autism Spectrum Disorder; Traumatic Brain Injury (TBI)
• Companies Mentioned: General Electric; Medtronic PLC; Koninklijke Philips N.V.; Shimadzu Corporation; EndoStim Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Neurotechnology Market Characteristics

3. Neurotechnology Market Trends And Strategies

4. Neurotechnology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Neurotechnology Growth Analysis And Strategic Analysis Framework

• 5.1. Global Neurotechnology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Neurotechnology Market Growth Rate Analysis
• 5.4. Global Neurotechnology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Neurotechnology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Neurotechnology Total Addressable Market (TAM)

6. Neurotechnology Market Segmentation

• 6.1. Global Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cognitive Disorders
• Pain Treatment
• Urinary And Faecal Incontinence
• Epilepsy
• Parkinson's Disease
• Hearing Conditions
• Sleep Disorder
• Depression
• Other Conditions
• 6.2. Global Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Imaging Modalities
• Neurostimulation
• Cranial Surface Measurement
• Neurological Implants
• Other Types
• 6.3. Global Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ambulatory Surgical Centers
• Hospitals
• Homecare Facilities
• Other End Uses
• 6.4. Global Neurotechnology Market, Sub-Segmentation Of Cognitive Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Alzheimer's Disease
• Attention Deficit Hyperactivity Disorder (ADHD)
• Dementia
• 6.5. Global Neurotechnology Market, Sub-Segmentation Of Pain Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chronic Pain
• Neuropathic Pain
• Acute Pain
• 6.6. Global Neurotechnology Market, Sub-Segmentation Of Urinary And Fecal Incontinence, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Overactive Bladder
• Neurogenic Bladder
• Fecal Incontinence Management
• 6.7. Global Neurotechnology Market, Sub-Segmentation Of Epilepsy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug-Resistant Epilepsy
• Seizure Management Devices
• 6.8. Global Neurotechnology Market, Sub-Segmentation Of Parkinson's Disease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Motor Symptoms Management
• Non-Motor Symptoms Management
• 6.9. Global Neurotechnology Market, Sub-Segmentation Of Hearing Conditions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tinnitus
• Hearing Loss Solutions
• 6.10. Global Neurotechnology Market, Sub-Segmentation Of Sleep Disorder, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Insomnia
• Sleep Apnea
• Restless Legs Syndrome
• 6.11. Global Neurotechnology Market, Sub-Segmentation Of Depression, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Major Depressive Disorder
• Treatment-Resistant Depression
• 6.12. Global Neurotechnology Market, Sub-Segmentation Of Other Conditions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Anxiety Disorders
• Autism Spectrum Disorder
• Traumatic Brain Injury (TBI)

7. Neurotechnology Market Regional And Country Analysis

• 7.1. Global Neurotechnology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Neurotechnology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Neurotechnology Market

• 8.1. Asia-Pacific Neurotechnology Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Neurotechnology Market

• 9.1. China Neurotechnology Market Overview
• 9.2. China Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Neurotechnology Market

• 10.1. India Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Neurotechnology Market

• 11.1. Japan Neurotechnology Market Overview
• 11.2. Japan Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Neurotechnology Market

• 12.1. Australia Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Neurotechnology Market

• 13.1. Indonesia Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Neurotechnology Market

• 14.1. South Korea Neurotechnology Market Overview
• 14.2. South Korea Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Neurotechnology Market

• 15.1. Western Europe Neurotechnology Market Overview
• 15.2. Western Europe Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Neurotechnology Market

• 16.1. UK Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Neurotechnology Market

• 17.1. Germany Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Neurotechnology Market

• 18.1. France Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Neurotechnology Market

• 19.1. Italy Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Neurotechnology Market

• 20.1. Spain Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Neurotechnology Market

• 21.1. Eastern Europe Neurotechnology Market Overview
• 21.2. Eastern Europe Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Neurotechnology Market

• 22.1. Russia Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Neurotechnology Market

• 23.1. North America Neurotechnology Market Overview
• 23.2. North America Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Neurotechnology Market

• 24.1. USA Neurotechnology Market Overview
• 24.2. USA Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Neurotechnology Market

• 25.1. Canada Neurotechnology Market Overview
• 25.2. Canada Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Neurotechnology Market

• 26.1. South America Neurotechnology Market Overview
• 26.2. South America Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Neurotechnology Market

• 27.1. Brazil Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Neurotechnology Market

• 28.1. Middle East Neurotechnology Market Overview
• 28.2. Middle East Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Neurotechnology Market

• 29.1. Africa Neurotechnology Market Overview
• 29.2. Africa Neurotechnology Market, Segmentation By Conditions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Neurotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Neurotechnology Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Neurotechnology Market Competitive Landscape And Company Profiles

• 30.1. Neurotechnology Market Competitive Landscape
• 30.2. Neurotechnology Market Company Profiles
  • 30.2.1. General Electric Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Shimadzu Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. EndoStim Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Neurotechnology Market Other Major And Innovative Companies

• 31.1. Elekta AB
• 31.2. Natus Medical Incorporated
• 31.3. Abbott
• 31.4. Boston Scientific Corporation
• 31.5. Cleveland Medical Devices Inc.
• 31.6. Nihon Kohden Corporation
• 31.7. LivaNova PLC
• 31.8. Siemens Healthcare Private Limited
• 31.9. Hitachi Medical Corporation
• 31.10. Cochlear Limited
• 31.11. Advanced Bionics AG (Sonova)
• 31.12. NeuroPace Inc.
• 31.13. NeuroSigma Inc.
• 31.14. NeuroMetrix Inc.
• 31.15. NeuroSky Inc.

32. Global Neurotechnology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Neurotechnology Market

34. Recent Developments In The Neurotechnology Market

35. Neurotechnology Market High Potential Countries, Segments and Strategies

• 35.1 Neurotechnology Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Neurotechnology Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Neurotechnology Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer